Drs. Westover and Zhou, UT Southwestern Medical Center (IMAGE)

UT Southwestern Medical Center

Drs. Westover and Zhou, UT Southwestern Medical Center

Caption

One of the leading goals of cancer research is a drug that would target RAS mutations, the most common oncogene. Work by UT Southwestern researchers Zhiewei Zhou, left, and Dr. Kenneth Westover, has identified a potential tactic for attacking RAS-driven cancers.

Credit

UT Southwestern

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.